Philip Noone reveals how Aalto BioReagents is identifying & developing treatments for emerging viruses

Business Matters with Karl Fitzpatrick
03/05/2022 16 min Episodio 176
Philip Noone reveals how Aalto BioReagents is identifying & developing treatments for emerging viruses

Listen "Philip Noone reveals how Aalto BioReagents is identifying & developing treatments for emerging viruses"

Descargar episodio Ver en sitio original

Episode Synopsis

Hosted on Acast. See acast.com/privacy for more information.

More episodes of the podcast Business Matters with Karl Fitzpatrick

Tim Ayling reveals how AI powered chatbots are being used to facilitate cyber attacks 07/06/2025
Stephen Felle from Fordel analyses the wealth of the nation and how to get better returns on savings 05/06/2025
Paul Prendergast from Kayna reveals why embedded insurance is becoming popular within the industry 05/06/2025
Enda Finan from Aleph highlights the benefits for brands that advertise on Spotify and Snapchat 05/06/2025
Economist, Jim Power, discusses the export opportunities for Irish businesses in the Arab world 26/05/2025
Cuty Gupta from Cozmotec outlines her unorthodox journey to becoming a tech entrepreneur 26/05/2025
Dr. Darryl Williams from Partsol reveals the benefits of cognitive AI for organisations 26/05/2025
Doug C. Brown from CEO Sales Strategies talks about Win Win Win and how it leads to revenue growth 21/05/2025
Andrea Dermody from Dermody reveals how to build a truly inclusive culture within an organisation 21/05/2025
Tony Ryan from Duneolas explains why his business has received financial backing from GPs 21/05/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA